MEREO BIOPHARMA GROUP PLC
MREO·589492107·US·ADR·Healthcare - Biotechnology-13D/G
MREO (MEREO BIOPHARMA GROUP PLC) is held by 32 institutional investors as of Q1 2026. Largest holders: BANK OF AMERICA CORP /DE/ ($2.7M), MILLENNIUM MANAGEMENT LLC ($1.2M), UBS Group AG ($491,742). Net institutional sentiment: Mixed.
32
Holders
Avg rating(9 Elite)
$5.4M
Total Value
37% (43)
Fund Consensus
13 buying - 22 selling
Who's Trading
ActivistECEcoR1 Capital, LLC8.4%May 15, 2026
ActivistNVNorthpond Ventures, LP0.0%Feb 17, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.0.0%Feb 13, 2026
Activist68683 Capital Management, LLC8.2%Jan 6, 2026
ActivistMIMangrove Partners IM, LLC4.9%Nov 14, 2025
ActivistRSRock Springs Capital Management LP4.2%May 15, 2025
ActivistADAdage Capital Management, L.P.1.1%May 12, 2025
13F: Insider & Congress:
Showing 1-20 of 43
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer